These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16554535)

  • 1. Protease variants, LDL, and coronary heart disease.
    Tall AR
    N Engl J Med; 2006 Mar; 354(12):1310-2. PubMed ID: 16554535
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular biology of PCSK9: its role in LDL metabolism.
    Horton JD; Cohen JC; Hobbs HH
    Trends Biochem Sci; 2007 Feb; 32(2):71-7. PubMed ID: 17215125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
    Cohen JC; Boerwinkle E; Mosley TH; Hobbs HH
    N Engl J Med; 2006 Mar; 354(12):1264-72. PubMed ID: 16554528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond LDL cholesterol, a new role for PCSK9.
    Akram ON; Bernier A; Petrides F; Wong G; Lambert G
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1279-81. PubMed ID: 20554949
    [No Abstract]   [Full Text] [Related]  

  • 5. What promise does PCSK9 hold?
    Kastelein JJ; Fouchier SW; Defesche JC
    J Am Coll Cardiol; 2005 May; 45(10):1620-1. PubMed ID: 15893177
    [No Abstract]   [Full Text] [Related]  

  • 6. PCSK9 and LDL cholesterol: unravelling the target to design the bullet.
    Costet P; Krempf M; Cariou B
    Trends Biochem Sci; 2008 Sep; 33(9):426-34. PubMed ID: 18672372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedicine. Lowering LDL--not only how low, but how long?
    Brown MS; Goldstein JL
    Science; 2006 Mar; 311(5768):1721-3. PubMed ID: 16556829
    [No Abstract]   [Full Text] [Related]  

  • 8. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population.
    Hooper AJ; Marais AD; Tanyanyiwa DM; Burnett JR
    Atherosclerosis; 2007 Aug; 193(2):445-8. PubMed ID: 16989838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorting the wheat from the chaff in familial hypercholesterolemia.
    Hooper AJ; Watts GF
    Clin Chem; 2015 Jan; 61(1):6-8. PubMed ID: 25391991
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of PCSK9: is this the way forward for managing residual risk?
    Chowdhury SR; Rees A
    Curr Opin Lipidol; 2012 Oct; 23(5):509-10. PubMed ID: 22964999
    [No Abstract]   [Full Text] [Related]  

  • 11. A conversation with Helen Hobbs.
    Hobbs H; Neill US
    J Clin Invest; 2015 Oct; 125(10):3725-6. PubMed ID: 26426073
    [No Abstract]   [Full Text] [Related]  

  • 12. The mystery of PCSK9.
    Attie AD
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1337-9. PubMed ID: 15297287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monogenic hypercholesterolemias: new genes, new drug targets].
    Mandel'shtam MIu; Vasil'ev VB
    Genetika; 2008 Oct; 44(10):1309-16. PubMed ID: 19062528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proprotein convertase subtilisin/kexin type 9, its variants and regulation of low-density lipoprotein cholesterol.
    Wierzbicki AS
    Curr Opin Lipidol; 2007 Apr; 18(2):227-9. PubMed ID: 17353672
    [No Abstract]   [Full Text] [Related]  

  • 15. JCL Roundtable: diagnosis of severe familial hypercholesterolemia.
    Brown WV; Rader DJ; Kane J
    J Clin Lipidol; 2013; 7(6):540-5. PubMed ID: 24314353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does mutant proprotein convertase neural apoptosis-regulated convertase 1 induce autosomal dominant hypercholesterolemia?
    Jirholt P; Adiels M; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1334-6. PubMed ID: 15297286
    [No Abstract]   [Full Text] [Related]  

  • 17. [PCSK9: a new gene involved in familial hypercholesteremia].
    Lambert G; Costet P; Krempf M; Lalanne F
    Med Sci (Paris); 2004 Dec; 20(12):1068-70. PubMed ID: 15581455
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the challenges of familial hypercholesterolemia screening: introduction.
    Hopkins PN
    J Clin Lipidol; 2010; 4(5):342-5. PubMed ID: 21122675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein receptor activity in Epstein-Barr virus-transformed lymphocytes from heterozygotes for the D374Y mutation in the PCSK9 gene.
    Holla ØL; Cameron J; Berge KE; Kulseth MA; Ranheim T; Leren TP
    Scand J Clin Lab Invest; 2006; 66(4):317-28. PubMed ID: 16777760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility gene card for: hyperlipoproteinemia, TYPE II.
    Kassner U; Wühle-Demuth M; Missala I; Humphries SE; Steinhagen-Thiessen E; Demuth I
    Eur J Hum Genet; 2014 Jul; 22(7):. PubMed ID: 24253857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.